Accelerate Diagnostics, Inc. (AXDX)

NASDAQ: AXDX · Real-Time Price · USD

1.190

+0.080 (7.21%)

At close: Feb 21, 2025, 4:00 PM

1.239

+0.049 (4.14%)

After-hours: Feb 21, 2025, 7:06 PM EST

Accelerate Diagnostics Market Cap

Accelerate Diagnostics has a market cap or net worth of $29.80 million as of February 21, 2025. Its market cap has increased by 75.31% in one year.

Market Cap

29.80M

Enterprise Value

67.86M

1-Year Change

75.31%

Ranking

#4704

Market Cap Chart

Since December 1, 1998, Accelerate Diagnostics's market cap has increased from $21.70M to $29.80M, an increase of 37.34%. That is a compound annual growth rate of 1.22%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	29.80M	-1.00%
Dec 31, 2024	30.10M	-47.19%
Dec 29, 2023	57.00M	-18.57%
Dec 30, 2022	70.00M	-79.56%
Dec 31, 2021	342.50M	-20.77%
Dec 31, 2020	432.30M	-53.19%
Dec 31, 2019	923.50M	48.16%
Dec 31, 2018	623.30M	-57.06%
Dec 29, 2017	1.45B	35.99%
Dec 30, 2016	1.07B	11.02%
Dec 31, 2015	961.40M	12.30%
Dec 31, 2014	856.10M	69.22%
Dec 31, 2013	505.90M	395.49%
Dec 31, 2012	102.10M	661.94%
Dec 30, 2011	13.40M	26.42%
Dec 31, 2010	10.60M	23.26%
Dec 31, 2009	8.60M	-63.40%
Dec 31, 2008	23.50M	-49.13%
Dec 31, 2007	46.20M	132.16%
Dec 29, 2006	19.90M	-34.32%
Dec 30, 2005	30.30M	44.98%
Dec 31, 2004	20.90M	-1.88%
Dec 31, 2003	21.30M	56.62%
Dec 31, 2002	13.60M	-16.05%
Dec 31, 2001	16.20M	575.00%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings